- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03379155
Internet-based Self-help for Negative Life Events (ZIEL)
ZIEL - Zurück Ins Eigene Leben - Internet-based Self-help for Negative Life Events
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bern, Switzerland, 3012
- University of Bern
-
Zürich, Switzerland, 8050
- Universität Zürich
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Negative life event in a period between two weeks and two years before the study
- Internet account
- Sufficient German language skills
- Informed consent
Exclusion Criteria:
- Persons with moderate or severe depressive symptoms
- Acute suicidality
- Psychotic disorder, bipolar disorder
- Severe, acute mental or physical disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Active Group
Internet-based self-help
|
The intervention provided is based on the principles of cognitive behavioral therapy (CBT) (Bachem & Maercker, 2013).
The manual integrates a variety of approaches validated as treatments for PTSD, anxiety disorders, or depression; the selection focuses on exercises which are intended to target the main symptoms of AjD, namely preoccupations (e.g.
constant rumination, excessive worry about the stressor) and failure to adapt (e.g.
sleep disturbance, difficulties concentrating, loss of interest in previously enjoyable activities).
|
No Intervention: Waiting List Group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adjustment Disorder - New Module 20 (ADNM-20)
Time Frame: 4-week
|
The ADNM-20 is a self-report assessment for adjustment disorder. It is aimed at adults who feel burdened by a critical life event. The ADNM-20 consists of two parts: an event list for recording stress and an item list for recording the resulting symptoms. In the event list, all burdens during the last two years are recorded and the subjectively highest burdens are named. On the basis of the item list, preoccupations and mismatch, the main symptom groups of the adaptation disorder according to ICD-11, as well as the concomitant symptoms of avoidance, depressiveness, anxiety, impulse control problems and functional impairment are recorded. The scale ranges from 0 (no stress) to 80 (high exposure). |
4-week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Brief Symptom Inventory - Short Version (BSI-18)
Time Frame: 4-week
|
The short version of the Brief Symptom Inventory (BSI-18) is an easily applicable, reliable and valid self-report measure in wide international use. It assesses the syndromes of somatisation, depression and anxiety by means of 6 items each. The global factor ranges from 0 (no symptoms) to 72 (high symptomatic burden). |
4-week
|
Beck Depression Inventory (BDI)
Time Frame: 4-week
|
The BDI is a 21-question multiple-choice self-report inventory, one of the most widely used psychometric tests for measuring the severity of depression. The score ranges from 0 (no symptoms) to 63 (severe depression). |
4-week
|
Short Form 12-Item Survey (SF-12)
Time Frame: 4-week
|
The SF-12 consists of 12 questions and is a general health questionnaire that provides information on the patient's state of health in more than 8 different dimensions. Physical and Mental Health Composite Scores (PCS & MCS) are computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health. |
4-week
|
Sense of Coherence Questionaire Revised (SOC-R)
Time Frame: 4-week
|
The SOC-R is a new conceptualization and operationalization of the resilience indicator SOC. The total score ranges from 13 (low) to 65 (high SOC). |
4-week
|
Questionnaire for measuring patient satisfaction (ZUF-8)
Time Frame: 4-week
|
The ZUF-8 is a self-assessment tool to assess the patient's satisfaction with regard to aspects of the clinic and treatment. The scale ranges from 8 (bad) to 32 (good satisfaction). |
4-week
|
Credibility/Expectancy Questionaire (CEQ)
Time Frame: 4-week
|
The CEQ is a scale for measuring treatment expectancy and rationale credibility for use in clinical outcome studies. The CEQ utilizes two scales during the administration (1-9, and 0-100%). |
4-week
|
System Usability Scale (SUS)
Time Frame: 4-week
|
The System Usability Scale (SUS) is a simple and technology-independent questionnaire to evaluate the usability of a system. The score ranges from 0 (worst) to 100 (best). |
4-week
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Andreas Maercker, Prof., Universität Zürich
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZIEL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adjustment Disorders
-
University of ArizonaCompletedStress | Stress, Psychological | Stress Reaction | Adjustment | Adjustment, Emotional | Adjustment, Social
-
Tel-Aviv Sourasky Medical CenterUnknownAdjustment Disorder
-
University Hospital, LilleCompleted
-
VistaGen Therapeutics, Inc.CompletedAdjustment Disorder With Anxious MoodUnited States
-
CHU de Quebec-Universite LavalLaval University; Canadian Cancer Society (CCS); Centre de recherche en cancérologie... and other collaboratorsUnknownCreating Meaning Following Cancer: An Intervention to Improve Existential and Global Quality of LifeAdjustment Disorder | Non-metastatic CancerCanada
-
Odense University HospitalRigshospitalet, Denmark; University of Southern DenmarkEnrolling by invitationAdjustment Disorder With Work InhibitionDenmark
-
University of BernSwiss Accident Insurance Fund SUVACompletedMental Disorder | Adjustment Disorders | Adjustment Impairment | AccidentSwitzerland
-
Cambridge Health AllianceThe Arnold P. Gold Foundation; The Arthur Vining Davis FoundationsCompletedDepression | Anxiety | Adjustment Disorder | Stress Related DisorderUnited States
-
Zhuan ZhangRecruiting
-
University of MiamiUniversity of Kansas; American Music Therapy AssociationCompleted
Clinical Trials on Internet-based self-help program
-
University of BernCompletedSelf-criticismSwitzerland
-
Helse Møre og Romsdal HFCompleted
-
Uppsala UniversityCompletedDepression | Cancer | AnxietySweden
-
Education University of Hong KongBaptist Oi Kwan Social ServiceCompletedSevere Mental IllnessHong Kong
-
University of BernCompletedPsychological Distress | Coronavirus | Adjustment, PsychologicalSwitzerland
-
University of BernSwiss Accident Insurance Fund SUVACompletedMental Disorder | Adjustment Disorders | Adjustment Impairment | AccidentSwitzerland
-
University of BernCompletedProlonged Grief SymptomsSwitzerland
-
Stockholm UniversityCompletedSocial Anxiety DisorderSweden
-
University of BernUniversity Hospital Inselspital, BerneTerminated
-
University of California, San FranciscoTobacco Related Disease Research ProgramCompletedCigarette SmokingUnited States